...
首页> 外文期刊>Leprosy review >Leprosy in Africa: a contrasted picture
【24h】

Leprosy in Africa: a contrasted picture

机译:非洲麻风病:对比鲜明的画面

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

There is no doubt that the goal of the Elimination of Leprosy as a public health problem, as adopted by the World Health Assembly in 1991, has had a very positive impact on the leprosy situation. Globally, more attention has been given to leprosy by political authorities and Ministries of Health during the last decades than ever before in history, and much progress has been achieved. This is also true for Africa: while a kind of routine had been prevailing for many years in often vertically organized leprosy services, a new impetus was given in all countries. The results of this are impressive. According to official statistics, the number of leprosy cases registered for treatment in the African Region of WHO has decreased by more than 50% between 1995 and 2003, mainly thanks to the generalization of the use of the WHO MDT regimens. The registered prevalence rate is now 0·8 per 10,000 for the whole Region. It is above 1 per 10,000 in only seven of the 46 countries of the Region (Angola, Central African Republic, Comoros, DR Congo, Madagascar, Mozambique and Tanzania), of which three countries only (Angola, Madagascar and Mozambique) are officially recognized at risk of not achieving the Elimination goal by the end of the year 2005. What is more, it has been reported from several countries where surveys have been carried out, that many registered patients should have long been discharged (patients having completed treatment, having disappeared or died who remain in the registers for years,...) or should not have been registered at all (re-registration of previously treated patients and cured patients, wrong diagnoses).
机译:毫无疑问,1991年世界卫生大会通过的消除麻风病这一公共卫生问题的目标对麻风病情产生了非常积极的影响。在全球范围内,过去几十年来,政治当局和卫生部对麻风病的关注程度超过历史,而且取得了很大进展。非洲也是如此:尽管在通常垂直组织的麻风病治疗中已经流行了许多年,但所有国家都获得了新的动力。其结果令人印象深刻。根据官方统计,在1995年至2003年间,在WHO世界卫生组织非洲区域登记治疗的麻风病病例数已减少了50%以上,这主要归功于WHO WHO MDT疗法的普遍使用。现在,整个区域的注册患病率为每10,000个中的0·8。在该区域46个国家中只有七个国家(安哥拉,中非共和国,科摩罗,刚果民主共和国,马达加斯加,莫桑比克和坦桑尼亚),这一比例高于每10,000个国家中的1个,其中只有三个国家(安哥拉,马达加斯加和莫桑比克)得到正式承认有可能在2005年底之前未达到消除目标的风险。此外,据一些进行调查的国家的报告,许多注册患者应该早已出院(患者已经完成治疗,失踪或死亡,但仍在登记簿中居住了多年,...)或根本不应该登记(重新登记先前治疗过的患者和治愈的患者,错误的诊断)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号